Benchmark Holdings plc (BHCCF) Research

Benchmark Holdings plc is dedicated to empowering the food and agriculture sectors by furnishing specialized knowledge, services, and products. The company's operations are divided into three core divisions: Genetics, Advanced Nutrition, and Health. Within its Genetics arm, Benchmark provides cutting-edge breeding technologies and facilities for species such as sea bass/bream, salmon, shrimp, and tilapia, delivering genetically superior ova. The Advanced Nutrition division focuses on creating and supplying vital nutritional and health products specifically for the aquaculture industry. Meanwhile, the Health segment offers crucial medicinal solutions for the aquaculture market, including treatments like Ectosan Vet and CleanTreat for sea lice. Founded in 2000 and headquartered in Sheffield, United Kingdom, Benchmark Holdings plc maintains a broad international presence, conducting business in diverse regions including the UK, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, other European countries, and worldwide.

Market snapshot

Symbol
BHCCF
Price
$0.37
Day change
0.00%
Market cap
$135.7M
P/E ratio
2.14x
52-week range
0.3658-0.3964
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Alterola Biotech, Inc. (ABTI)
  • Craftport Cannabis Corp. (BHHKF)
  • Cipher Pharmaceuticals Inc. (CPHRF)
  • China Evergrande New Energy Vehicle Group Limited (EVGRF)
  • Mayne Pharma Group Limited (MAYNF)
  • Orpea S.A. (ORPEF)
  • Profile Solutions, Inc. (PSIQ)
  • Silence Therapeutics plc (SLNCF)

Open Benchmark Holdings plc (BHCCF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.